ACIU
Price:
$2.4
Market Cap:
$196.97M
AC Immune S.A. is a biotech firm operating at the clinical stage, dedicated to pioneering, formulating, and advancing therapeutic agents and diagnostic tools. Its core mission is addressing neurodegenerative conditions rooted in protein misfolding, both preventatively and therapeutically. Leveraging its proprietary SupraAntigen and Morphomer platforms, the company engineers a range of vaccines, antibodies, and small molecules specifically designed to engage with aberrantly folded proteins implicated across various neurodegenerative disorders. Its pipeline features Crenezumab, a humanized, conformation-specific monoclonal antibody currently undergoing a Phase II clinical prevention trial for ...[Read more]
Industry
Biotechnology
IPO Date
2016-09-23
Stock Exchange
NASDAQ
Ticker
ACIU
According to AC Immune S.A.’s latest financial reports and current stock price. The company's current ROE is -123.98%. This represents a change of 273.80% compared to the average of -33.17% of the last 4 quarters.
The mean historical ROE of AC Immune S.A. over the last ten years is -37.76%. The current -123.98% ROE has changed 228.37% with respect to the historical average. Over the past ten years (40 quarters), ACIU's ROE was at its highest in in the March 2019 quarter at 26.29%. The ROE was at its lowest in in the March 2026 quarter at -46.94%.
Average
-37.76%
Median
-30.10%
Minimum
-156.78%
Maximum
16.68%
Discovering the peaks and valleys of AC Immune S.A. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 353.56%
Maximum Annual ROE = 16.68%
Minimum Annual Increase = -272.29%
Minimum Annual ROE = -156.78%
| Year | ROE | Change |
|---|---|---|
| 2025 | -156.78% | 245.69% |
| 2024 | -45.35% | 34.33% |
| 2023 | -33.76% | -19.37% |
| 2022 | -41.87% | 33.05% |
| 2021 | -31.47% | 9.50% |
| 2020 | -28.74% | -272.29% |
| 2019 | 16.68% | -158.15% |
| 2018 | -28.68% | 26.90% |
| 2017 | -22.60% | 353.56% |
| 2016 | -4.98% | -117.47% |
The current ROE of AC Immune S.A. (ACIU) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-78.63%
5-year avg
-61.84%
10-year avg
-37.76%
AC Immune S.A.’s ROE is greater than Aldeyra Therapeutics, Inc. (-57.34%), greater than Cellectis S.A. (-80.61%), greater than Alto Neuroscience, Inc. (-47.22%), greater than Silence Therapeutics plc (-121.71%), greater than Amarin Corporation plc (-7.34%), greater than Contineum Therapeutics, Inc. Class A Common Stock (-27.09%), greater than Lyell Immunopharma, Inc. (-85.71%), greater than Mereo BioPharma Group plc (-81.25%), greater than Annexon, Inc. (-101.19%), greater than Alpha Tau Medical Ltd. (-73.23%),
| Company | ROE | Market cap |
|---|---|---|
| -57.34% | $118.23M | |
| -80.61% | $299.24M | |
| -47.22% | $798.04M | |
| -121.71% | $327.33M | |
| -7.34% | $331.54M | |
| -27.09% | $446.39M | |
| -85.71% | $297.28M | |
| -81.25% | $49.39M | |
| -101.19% | $586.02M | |
| -73.23% | $883.39M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AC Immune S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like AC Immune S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is AC Immune S.A.'s ROE?
How is the ROE calculated for AC Immune S.A. (ACIU)?
What is the highest ROE for AC Immune S.A. (ACIU)?
What is the 3-year average ROE for AC Immune S.A. (ACIU)?
What is the 5-year average ROE for AC Immune S.A. (ACIU)?
How does the current ROE for AC Immune S.A. (ACIU) compare to its historical average?